Jennifer Ruddock | Head-Investor Relations |
Howard Robin | President and Chief Executive Officer |
Mary Tagliaferri | Chief Medical Officer |
Gil Labrucherie | Chief Financial Officer |
Jonathan Zalevsky | Chief Scientific Officer |
Jessica Fye | JPMorgan |
Chris Shibutani | Cowen |
Paul Choi | Goldman Sachs |
George Farmer | BMO Capital Markets |
Alexander Duncan | Piper Jaffray |
Andy Hsieh | William Blair |
Asthika Goonewardene | Bloomberg Intelligence |
Good day, ladies and gentlemen, and welcome to the Nektar Therapeutics Q4 2018 Financial Results. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to introduce your host for today's conference, Ms. Jennifer Ruddock, Head of Investor Relations. Ma'am, you may begin.